Home » Topics » Regulatory » Patents

Patents
RSS

Legionella vaccine described by U.S. researchers

Feb. 7, 1997

Nonantiresorptive substituted bisphosphonate disclosed by Gador

Feb. 7, 1997

Antiallergic/antiinflammatory agents from Senju

Feb. 7, 1997

Japanese researchers describe triazole antifungals

Feb. 7, 1997

Il Yang develops antitumor/immunostimulating proteoglycan

Feb. 7, 1997

Rockefeller University discloses antibiotic peptides

Feb. 7, 1997

Merck describes improved chemotherapeutic agents

Feb. 7, 1997

Peptide derivatives with antiinflammatory properties described by U.S. researchers

Feb. 7, 1997

Tsumura describes agents for dermatitis

Feb. 7, 1997

Chymase inhibitors from Green Cross

Feb. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...